| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 05/04/2000 | CA2348770A1 Stromal cell use |
| 05/04/2000 | CA2348634A1 Methods for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 05/04/2000 | CA2348430A1 Ovary-specific genes and proteins |
| 05/04/2000 | CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals |
| 05/04/2000 | CA2329607A1 Biological material for treating periodontal diseases |
| 05/03/2000 | EP0997473A1 Natural antitumor or antiviral substances and use of the same |
| 05/03/2000 | EP0996636A1 The ha-1 antigen |
| 05/03/2000 | EP0996459A1 Use of exendins and agonists thereof for the reduction of food intake |
| 05/03/2000 | EP0669977B1 Transformed endothelial cells |
| 05/03/2000 | EP0559884B1 Viral recombinant vectors for expression in muscle cells |
| 05/03/2000 | CN1252074A Stimulation of red blood cell production |
| 05/03/2000 | CN1251999A Stable extract of hypericum perforatum L.,method for producing same and corresponding pharmaceutical preparations |
| 05/03/2000 | CN1251998A Facililation of wound healing with CM101/GBS toxin |
| 05/03/2000 | CN1251997A Treatment of chronic inflammatory diseases with CM 101/GBS toxin |
| 05/03/2000 | CN1251769A Ointment for treating burn and scald |
| 05/03/2000 | CN1251762A Process for preparing Chinese medicine 'Buxueyimu Particles' |
| 05/03/2000 | CN1251760A Medicine |
| 05/03/2000 | CN1251759A Pure pallas pit viper powder and its preparing method |
| 05/03/2000 | CN1051936C Quick-action defatting liquid and its preparing method |
| 05/03/2000 | CN1051935C Chinese herbal medicine for senile dementia and preparation thereof |
| 05/03/2000 | CN1051934C Chinese herbal medicine for epiplepsy and its preparation |
| 05/03/2000 | CN1051932C Drug for acne and its preparation |
| 05/03/2000 | CN1051927C Navel medicine bag for treatment of hypertension and cerebral arteriosclerosis and preparation |
| 05/03/2000 | CN1051926C Anti-cancer Chinese drug capsule |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057300 Introducing expression vector comprising gene encoding p21 and expression vector comprising second gene encoding immunotherapeutic agent, genetic therapeutic, cytokine or prodrug converting enzyme to treat restenosis |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6056978 Use of hyperimmune milk to prevent suppression of T-lymphocyte production |
| 05/02/2000 | US6056964 Delaying or preventing the growth or spread of a malignant neoplasm by administering killed cells of mycobacterium vaccae |
| 05/02/2000 | US6056952 Selective elimination of T cells that recognize specific preselected targets |
| 05/02/2000 | US6056951 Method of reducing the chance of attack of cells in a body by the cellular immune system |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2104014C Structural gene of pneumococcal protein |
| 05/02/2000 | CA2076018C Docosahexaenoic acid, methods for its production and compounds containing the same |
| 04/27/2000 | WO2000023592A2 Minimal promoters and uses thereof |
| 04/27/2000 | WO2000023587A2 Gene therapy of alzheimer's disease by delivery of an encoded apolipoprotein e |
| 04/27/2000 | WO2000023573A2 Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies |
| 04/27/2000 | WO2000023571A2 A method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023569A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | WO2000023567A2 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/27/2000 | WO2000023546A1 Method of extracting lipids from marine and aquatic animal tissues |
| 04/27/2000 | WO2000023471A2 Use of a cytokine-producing lactococcus strain to treat colitis |
| 04/27/2000 | WO2000023116A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | WO2000023106A1 Bacterial extract as oral adjuvant |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023088A2 Methods of administering adenoviral vectors |
| 04/27/2000 | WO2000023053A2 Artificial antigen-specific cells and related methods |
| 04/27/2000 | WO2000023008A2 Cardiovascular components for transplantation and methods of making thereof |
| 04/27/2000 | WO1999061586A9 Promotion of cell differentiation by initially passaged cells |
| 04/27/2000 | WO1999061085A9 Method and compositions for treatment of cancers |
| 04/27/2000 | WO1999006544A8 Membrane-bound cytokine compositions and methods of modulating an immune response using same |
| 04/27/2000 | CA2749553A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 04/27/2000 | CA2348153A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | CA2348068A1 Adeno-associated vectors for expression of factor viii by target cells |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347369A1 Minimal promoters and uses thereof |
| 04/27/2000 | CA2347083A1 Methods of administering adenoviral vectors |
| 04/27/2000 | CA2346841A1 Cardiovascular components for transplantation and methods of making thereof |
| 04/27/2000 | CA2346152A1 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 04/26/2000 | EP0995802A2 Method for the delivery of nucleic acids to cells in vitro or ex vivo |
| 04/26/2000 | EP0995795A2 Human recombinant cell for bone or cartilage cell binding |
| 04/26/2000 | EP0995442A1 Use of milk from equines for the manufacture of a preparation for the treatment of bucco-dental troubles |
| 04/26/2000 | EP0994958A2 Selective regulation of adenovirus production |
| 04/26/2000 | EP0994953A1 Expression system for production of therapeutic proteins |
| 04/26/2000 | EP0994728A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 04/26/2000 | EP0994716A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 04/26/2000 | EP0925305B1 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity |
| 04/26/2000 | EP0925304B1 Cyclitol containing carbohydrates from human tissue which regulate glycogen metabolism |
| 04/26/2000 | EP0832130B1 Separating polymerized from unpolymerized hemoglobin using hydroxyapatite |
| 04/26/2000 | EP0830099B1 Apparatus and methods for cell isolation and collection |
| 04/26/2000 | EP0830061B1 Moist bacteriocin disinfectant wipes and methods of using the same |
| 04/26/2000 | EP0633930B1 In vitro generation of human dendritic cells |
| 04/26/2000 | CN1251529A Use of bacterial cell wall extracts for treating, preventing or removing protozoa or parasitism diseases |
| 04/26/2000 | CN1251528A Targeted system for removing tumor cells from cell populations |
| 04/26/2000 | CN1251388A Micro-capsule peridium growth regulator |
| 04/26/2000 | CN1251309A Method for preparing medicinal absinthium extracted liquor and electro-moxibustion apparatus using said extracted liquor |
| 04/26/2000 | CN1251308A Chinese medicine for quickly ard radically curing rabies |
| 04/26/2000 | CN1251300A Traditional Chinese medicine compounded preparation for preventing and treating rabies and preparation method thereof |
| 04/26/2000 | CN1051712C Medicine for treating rheumatism |
| 04/26/2000 | CN1051710C Complex ant capsule |
| 04/26/2000 | CN1051709C Atomized pudendum-cleaning medicine preparation |
| 04/26/2000 | CN1051707C Thymus-gland protein oral solution |
| 04/25/2000 | US6054560 Mitogen activated protein kinase, FRK |
| 04/25/2000 | US6054142 Biocompatible devices with foam scaffolds |
| 04/25/2000 | US6054124 A milk or a polypeptide subfraction of milk obtained from the allergen treated host, for preventing or alleviating allergic reactions |
| 04/25/2000 | US6054121 Modulation of immune responses in blood-borne mesenchymal cells |
| 04/25/2000 | CA1340970C Lipase from gastric mucosa |
| 04/21/2000 | CA2251265A1 Process for lipid extraction of aquatic animal tissues producing a dehydrated residue |
| 04/20/2000 | WO2000022430A2 Neisseria genomic sequences and methods of their use |
| 04/20/2000 | WO2000022137A2 Selectively replicating viral vectors |
| 04/20/2000 | WO2000022136A2 Recombinant e1a deleted adenoviral vectors |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021591A1 Method for production of stroma-free hemoglobin |
| 04/20/2000 | WO2000021562A1 Method to prevent xenograft transplant rejection |
| 04/20/2000 | WO2000021519A1 Drug preparation 'histochrome' for treating acute myocardial infarction and ischaemic heart diseases |
| 04/20/2000 | WO2000021518A1 Drug preparation 'histochrome' for treating ocular conditions |